
    
      A randomised single blinded intervention study in high-risk newborns vaccinated at the age of
      6 weeks with BCG or placebo.

      Inclusion: high-risk was defined as either a mother or a father and a sibling with present or
      past atopic disease.

      Exclusion: maternal infection in the last week of pregnancy, the use of immunomodulatory
      drugs or antibiotics during pregnancy (mother), the use of antibiotics directly post-partum
      (newborn)
    
  